{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1364233270487396992.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1681/asn.2007121272"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/00001751-200810000-00021"}}],"dc:title":[{"@value":"Successful Treatment of Class V+IV Lupus Nephritis with Multitarget Therapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1384233270487396997","@type":"Researcher","foaf:name":[{"@value":"Hao Bao"}]},{"@id":"https://cir.nii.ac.jp/crid/1384233270487396993","@type":"Researcher","foaf:name":[{"@value":"Zhi-Hong Liu"}]},{"@id":"https://cir.nii.ac.jp/crid/1384233270487396994","@type":"Researcher","foaf:name":[{"@value":"Hong-Lang Xie"}]},{"@id":"https://cir.nii.ac.jp/crid/1384233270487396996","@type":"Researcher","foaf:name":[{"@value":"Wei-Xin Hu"}]},{"@id":"https://cir.nii.ac.jp/crid/1384233270487396992","@type":"Researcher","foaf:name":[{"@value":"Hai-Tao Zhang"}]},{"@id":"https://cir.nii.ac.jp/crid/1384233270487396995","@type":"Researcher","foaf:name":[{"@value":"Lei-Shi Li"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10466673"}],"prism:publicationName":[{"@value":"Journal of the American Society of Nephrology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2008-10","prism:volume":"19","prism:number":"10","prism:startingPage":"2001","prism:endingPage":"2010"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/00001751-200810000-00021"}],"createdAt":"2008-07-03","modifiedAt":"2023-04-10","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050564288768429696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Investigation on the benefits of mycophenolate mofetil and therapeutic drug monitoring in the treatment of Japanese patients with lupus nephritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004234756531072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711656100864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204243569792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Meta-Analysis of Randomized Controlled Trials Comparing Tacrolimus with Intravenous Cyclophosphamide in the Induction Treatment for Lupus Nephritis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204870154240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Successful Treatment of Class IV+V Lupus Nephritis with Combination Therapy of High-dose Corticosteroids, Tacrolimus and Intravenous Cyclophosphamide"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681421661440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1. Systemic Lupus Erythematosus."},{"@language":"ja","@value":"1．全身性エリテマトーデス"},{"@value":"全身性エリテマトーデス"},{"@language":"ja-Kana","@value":"ゼンシンセイ エリテマトーデス"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681423840512","@type":"Article","resourceType":"other","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"11. Recent Progress in the Treatment of Lupus Nephritis"},{"@language":"ja","@value":"11．ループス腎炎治療の新展開"},{"@value":"教育講演 ループス腎炎治療の新展開"},{"@language":"ja-Kana","@value":"キョウイク コウエン ループスジンエン チリョウ ノ シン テンカイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390860929791490432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Remission Induction of IgG4-related Membranous Nephropathy with Multitarget Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892099516416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Treatment of pediatric-onset lupus nephritis : a proposal of optimal therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367073783808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological insights into lupus glomerulonephritis in Japanese and Asians"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1681/asn.2007121272"},{"@type":"CROSSREF","@value":"10.1007/s10157-011-0434-0_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.1093/rheumatology/key009_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.1620/tjem.227.281_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.2169/naika.101.2712_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.1007/s10157-017-1381-1_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.1007/s10157-018-1590-2_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.1177/0961203314528553_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.52.9366_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.2169/naika.100.1227_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.1023-22_references_DOI_CQG9WvGyBjQHVF2ghNDJb9CJXpM"}]}